Document is current
Any future updates will be listed below
-
Authors
Villalard, Benjamin https://orcid.org/0000-0002-4187-6389
Boltjes, Arjan https://orcid.org/0000-0002-6338-051X
Reynaud, Florie https://orcid.org/0000-0002-1653-7377
Imbaud, Olivier
Thoinet, Karine
Timmerman, Ilse
Croze, Séverine
Theoulle, Emy
Atzeni, Gianluigi
Lachuer, Joël
Molenaar, Jan J.
Tytgat, Godelieve A. M.
Delloye-Bourgeois, Céline https://orcid.org/0000-0002-7162-0034
Castellani, Valérie https://orcid.org/0000-0001-9623-9312
-
Funding
Funding for this research was provided by:
Institut National Du Cancer (PLBIO18-161)
Fondation ARC pour la Recherche sur le Cancer (PJA20181207900)
- License Information
-
More Information
Article History
Received: 21 September 2023
Accepted: 16 October 2024
First Online: 6 November 2024
Competing interests
: V.C. and C.D.B. declare the following competing interest: both are scientific advisors for the European Research Biological Center (ERBC) group. G.A. is employed by Cellenion, a BICO company. B.V., F.R., A.B., O.I., K.T., E.T., I.T., S.C., J.L., J.J.M., and G.T. declare no competing interests.
